Anemia Refractory
Mostrando 1-12 de 22 artigos, teses e dissertações.
-
1. Existe realmente tratamento para o vitiligo? Se sim, qual é o melhor?
Sim, existe tratamento para pessoas com o diagnóstico de vitiligo, os resultados de cada proposta terapêutica, entretanto, podem variar de paciente para paciente. Por esse motivo, a estratégia terapêutica para o vitiligo é individualizada. Não há, até o momento, bases científicas para a indicação de um tratamento único ideal para todos os port
Núcleo de Telessaúde NUTES PE. Publicado em: 12/06/2023
-
2. Evans syndrome in male lupus patient: case report
RESUMO A síndrome de Evans (SE) é uma doença autoimune rara de etiologia desconhecida; ocorre quando há combinação de anemia hemolítica autoimune (AHAI) com trombocitopenia, acompanhada ou não de neutropenia imune. Essa síndrome se enquadra em um tipo variável especial da AHAI a quente, podendo se relacionar com doenças reumatológicas, como lúpu
J. Bras. Patol. Med. Lab.. Publicado em: 02/09/2019
-
3. Refractory ascites and graft dysfunction in early renal transplantation
Resumo A ocorrência de ascite no pós-Transplante Renal (TR) é infrequente, podendo ser consequência de complicações cirúrgicas ou médicas. Caso clínico: 61 anos, masculino, antecedentes de hipertensão arterial, carcinoma da língua e hábitos alcoólicos 12-20g/dia. Doença renal crônica secundária à doença renal poliquística autossômica domi
J. Bras. Nefrol.. Publicado em: 18/03/2019
-
4. Salvaged single-unit cord blood transplantation for 26 patients with hematologic malignancies not in remission
Treatments for patients with hematologic malignancies not in remission are limited, but a few clinical studies have investigated the effects of salvaged unrelated cord blood transplantation (CBT). We retrospectively studied 19 patients with acute leukemia, 5 with myelodysplastic syndrome (MDS with refractory anemia with excess blasts [RAEB]), and 2 with non-
Braz J Med Biol Res. Publicado em: 27/03/2015
-
5. Histopathological evaluation of the bone marrow in refractory anemia with ring sideroblasts and thrombocytosis associated to the JAK2-V617F mutation
Rev. Bras. Hematol. Hemoter.. Publicado em: 2014-01
-
6. Síndromes Mielodisplásicas: enfoque epidemiológico e clínico em serviço de referência de alta complexidade
As Síndromes Mielodisplásicas (SMD) caracterizam um grupo de doenças de ordem clonal hematopoética evidenciadas por estudos em todo o mundo. Estudos epidemiológicos que abordem as características sociodemográficas e clínicas, com abordagem da sobrevida e evolução leucêmica dos casos não são encontrados na literatura brasileira, o que requer inve
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 14/09/2011
-
7. Screening for hotspot mutations in PI3K, JAK2, FLT3 and NPM1 in patients with myelodysplastic syndromes
INTRODUCTION: Myelodysplastic syndromes encompass a heterogeneous group of clonal hematopoietic stem cell disorders characterized by ineffective hematopoiesis, refractory cytopenia and a tendency to progress toward acute myeloid leukemia. The accumulation of genetic alterations is closely associated with the progression of myelodysplastic syndromes toward ac
Clinics. Publicado em: 2011
-
8. Gemcitabina e ifosfamida no tratamento do linfoma de Hodgkin refratário ou recidivado após múltiplas terapias
Patients with Hodgkin's lymphoma relapsed after or refractory to multiple therapies (rHL) have a dismal prognosis. Monotherapy with gemcitabine can promote an overall response rate of about 40% in these patients and its association with alkylating agents can provide better results. We retrospectively evaluated 17 rHL cases. All were treated with the combinat
Revista Brasileira de Hematologia e Hemoterapia. Publicado em: 2007-12
-
9. Case report of lymph nodal, hepatic and splenic tuberculosis in an HIV-positive patient
We describe a case of a male patient, 38 years old, HIV-positive (most recent CD4 count about 259/mm³), with abdominal pain, nausea, vomiting, anorexia, weight loss, and vespertine high fever with chills. His hemogram showed normocytic and normochromic anemia, with a high erythrocyte sedimentation rate (ESR) and gross granulations in the neutrophils. Transa
Brazilian Journal of Infectious Diseases. Publicado em: 2006-04
-
10. Association of HLA-linked hemochromatosis with idiopathic refractory sideroblastic anemia.
Five of seven patients with idiopathic refractory sideroblastic anemia carried an HLA-A3 alloantigen (relative risk, 7.3; P = 0.02). The significance of this association was strengthened by study of two pedigrees. An abnormality in iron metabolism was found in two siblings who had an HLA-A3,B14 haplotype in common with the first proband. A second proband wit
-
11. Late-onset X-linked sideroblastic anemia. Missense mutations in the erythroid delta-aminolevulinate synthase (ALAS2) gene in two pyridoxine-responsive patients initially diagnosed with acquired refractory anemia and ringed sideroblasts.
X-linked sideroblastic anemia (XLSA) is caused by mutations of the erythroid-specific delta-aminolevulinate synthase gene (ALAS2) resulting in deficient heme synthesis. The characteristic hypochromic, microcytic anemia typically becomes manifest in the first three decades of life. Hematologic response to pyridoxine is variable and rarely complete. We report
-
12. THE EXCRETION OF PORPHYRIN IN REFRACTORY AND APLASTIC ANEMIA